CD38 expression on CD8+ T cells in human immunodeficiency virus 1-positive adults treated with HAART

Acta Virologica

Volumn 47, Issue 2, 2003, Pages 121-124

  Beran, O ^a   Holub, M ^a   Spala J ^a   Kalanin, J ^b   Stankova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

CD38; CD8+; Flow cytometry; HAART; HIV 1

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD8 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CARRIER; DISEASE COURSE; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LYMPHOCYTE COUNT; MALE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS REPLICATION;

ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, CD38; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0042362089     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bergamini A, Faggioli E, Bolacchi F, Gessani S, Cappannoli L, Uccella I, Demin F, Capozzi M, Cicconi R, Placido R, Vendetti S, Colizzi GM, Rocchi G (1999): Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J. Infect. Dis. 179, 832-842.
2. Bouscarat F, Levacher M, Landman R, Muffat-Joly M, Girard PM, Saimot AG, Brun-Vezinet F, Sinet M (1998): Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 12, 1267-1273.
3. Ferbas J (1998): Perspectives on the role of CD8+ cell suppressor factors and cytotoxic T lymphocytes during HIV infection. AIDS Res. Hum. Retroviruses 14 (Suppl. 2), S153-S160.
4. Gea-Banacloche JC, Clifford Lane H (1999): Immune reconstitution in HIV infection. AIDS 13 (Suppl. A), S25-S38.
5. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R (1993): Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 6, 904-912.
6. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, Hultin LE, Jamieson BD, Margolick JB, Rinaldo CR Jr, Phair JP, Detels R (2002): Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 29, 346-355.
7. Ho HN, Hultin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce D, Chou CC, O'Rourke S, Taylor JM, Giorgi JV (1993): Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens, J. Immunol. 150, 3070-3079.
8. Liu Z, Hultin LE, Cumberland WG, Hultin P, Schmid I, Matud JL, Detels R, Giorgi JV (1996): Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Cytometry 26, 1-7.
9. Plana M, Garcia F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barcelo JJ, Vidal, C, Cruceta A, Miro JM, Gatell JM (2000): Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 14, 1921-1933.
10. Savarino A, Bottarel F, Malavasi F, Dianzani U (2000): Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS 14, 1079-1089.
11. Wong JK, Gunthard HF, Havlir DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E, Richman DD (1997): Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc. Natl. Acad. Sci. USA 94, 12574-12579.